Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Compass Pathways Patents – Key Insights and Stats - Insights;Gate
COMPASS Pathways Granted Patent Covering Use of Its Psilocybin ...
Compass Pathways Granted Its Tenth Overall Patent Related To Psilocybin ...
COMPASS Pathways Acquires Patent for Psilocybin, Which May Help with ...
Compass Pathways Stock Extends Gains on New Patent for Psilocybin ...
Compass Pathways Streamlines Operations with Workforce Reduction and ...
CMPS | Обзор IPO COMPASS Pathways | Анализ IPO CMPS
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Given Consensus Rating ...
Compass Pathways Psilocybin Patent Upheld | Cannabis Law Report
Compass Pathways Psilocybin Patent Upheld | Psychedelic Spotlight
COMPASS Pathways Is Trying to Patent Psilocybin for More Mental Health ...
COMPASS PATHWAYS files patent for 218 novel psychedelic drugs : r ...
How Does COMPASS Pathways Company Work? – CanvasBusinessModel.com
COMPASS Pathways Careers | Levels.fyi
The Competitive Landscape of COMPASS Pathways – CanvasBusinessModel.com
Compass Pathways establishes research collaboration with Mindful Health ...
Compass Pathways Plc - Drug pipelines, Patents, Clinical trials - Synapse
Pipeline overview | Compass Pathways
London's COMPASS Pathways gets $285M funding boost to advance ...
Compass Pathways
This Week in Psychedelic Stocks: Compass Pathways Wins Patent Battle ...
NEW MindMed MDMA trials, Compass Pathways Patent, Small Pharma DMT ...
COMPASS Pathways - Tripsitter
Compass Pathways (NASDAQ:CMPS) Stock Price News
Compass Pathways Soars on Phase 3 Psilocybin Trial Success
Compass Pathways Successfully Achieves Primary Endpoint in Second Phase ...
COMPASS Pathways logo in transparent PNG and vectorized SVG formats
Compass Pathways Establishes Strategic Collaboration with Radial to ...
Compass Pathways meets primary endpoint in Phase 3 trial of psilocybin ...
COMPASS Pathways plc Stock — CMPS Overview — Roic AI
Compass Pathways PLC 8-K Report: Key Announcements for January 2025 ...
COMPASS Pathways Jobs | Levels.fyi
Compass Pathways Wins FDA Green Light for PTSD Trial as Psilocybin ...
COMPASS Pathways Announces Positive Results From Groundbreaking Phase ...
CMPS News Today | Why did Compass Pathways stock drop today?
COMPASS PATHWAYS PLC (CMPS): análisis VRIO – DCFmodeling.com
COMPASS Pathways plc announces financial results and business ...
Digital technologies | Compass Pathways
Compass Pathways Announces Second Quarter 2025 Financial Results and ...
MindMed Delays Project Lucy & Compass Pathways Has a Challenged Patent ...
Compass Pathways IPO - AmeriVet Securities
Compass Pathways has just released topline results from the first-ever ...
Compass Pathways | Biotechnology Company
Is Compass Pathways Poised for Success? | Psychedelic Invest
Working at COMPASS Pathways | Glassdoor.co.uk
CMPS Insider Trading | Compass Pathways Buys and Sells
As COMPASS Pathways continues its attempts to build a psychedelic ...
Compass Pathways Rises 10% After Positive Phase 3 Results for COMP360 ...
Compass Pathways To Start Phase II Trial For Psilocybin PTSD Therapy ...
Compass Career Pathways | Kodiak College | Kodiak College
COMPASS Pathways Plc ADR (CMPS) Price Forecast: Bullish Reversal Gains ...
COMPASS Pathways announces pricing of upsized initial public offering
COMPASS Pathways plc (CMPS) Stock Price, News, Quote & History - Yahoo ...
COMPASS Pathways plc (CMPS) DCF Excel Template – DCFmodeling.com
Compass Pathways – World Social Media Awards
About COMPASS Pathways | Our Values & Mental Health Innovations
About Compass Pathways | Our Values & Mental Health Innovations
A Look at Compass Pathways and Clinical Results : psychedelicinvest
Compass Pathways Announces Dosing Complete for All Participants in Part ...
COMPASS pathways brand generation - Projects - Like Sherbet
Free Divided Compass Pathways Image - Aerial, Symmetry, Compass ...
Reality Check: Reflections on Compass Pathways' Phase IIb Topline Results
Compass pathways, psychedelic patents and pharma: Drug reform advocacy ...
Compass Pathways' Series B Pitch Deck Raised $80 Million for ...
New Filing Challenges Compass Pathways’ Infamous Patent on Synthetic ...
Compass Group Patents Key Insights & Stats - Insights;Gate
Compass Pathways: Forging Independent Path With Competition Nearing ...
Compass Pathways' Phase 2B study, the largest scale psychedelics ...
COMPASS Pathways' Psilocybin Patent Questioned By UK Patent Examiner
Comprehensive Analysis of Compass Pathways: $CMPS | Psychedelic Vantage ...
COMPASS Pathways: Private Placement Buys Less Time Than Expected ...
Compass Pathways' Opens Trading at $23.40 – Above Expected Range ...
COMPASS Pathways: Accelerating Patient Access To Evidence Based ...
Compass Pathways: Will The Stock Rally Last?
Vice Report: New Filing Challenges Compass Pathways’ Infamous Patent on ...
International Intellectual Property Law Association (IIPLA) on LinkedIn ...
The Top Companies Leading Psilocybin Research & Therapy
slide4
slide13
Portfolio
slide12
slide26
slide20
The Psychedelic News Feed - Psychedelic Alpha
slide15
Participants - Patent Pathways®
slide21
slide22
With Promise of Legalization, Psychedelic Companies Joust Over Future ...
slide11
slide9
slide14
Patent Pathways® (a 501(c)(3) organization) posted on LinkedIn
